In this video interview, David Morton, PhD, director of biostatistics at Certara, reflects on the growing role of Bayesian ...
In the 20th-century statistics wars, Bayesians were underdogs. Now their methods may help speed treatments to market.
As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results